Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2007 1
2009 1
2011 4
2012 3
2013 1
2014 5
2015 3
2016 4
2017 6
2018 10
2019 11
2020 7
2021 15
2022 11
2023 18
2024 13
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for edoardo sc
Search for Eduardo SC instead (1 results)
Evidence-based guidelines for the pharmacological treatment of migraine.
Ornello R, Caponnetto V, Ahmed F, Al-Khazali HM, Ambrosini A, Ashina S, Baraldi C, Bellotti A, Brighina F, Calabresi P, Casillo F, Cevoli S, Cheng S, Chiang CC, Chiarugi A, Christensen RH, Chu MK, Coppola G, Corbelli I, Crema S, De Icco R, de Tommaso M, Di Lorenzo C, Di Stefano V, Diener HC, Ekizoğlu E, Fallacara A, Favoni V, Garces KN, Geppetti P, Goicochea MT, Granato A, Granella F, Guerzoni S, Ha WS, Hassan A, Hirata K, Hoffmann J, Hüssler EM, Hussein M, Iannone LF, Jenkins B, Labastida-Ramirez A, Laporta A, Levin M, Lupica A, Mampreso E, Martinelli D, Monteith TS, Orologio I, Özge A, Pan LH, Panneerchelvam LL, Peres MFP, Souza MNP, Pozo-Rosich P, Prudenzano MP, Quattrocchi S, Rainero I, Romanenko V, Romozzi M, Russo A, Sances G, Sarchielli P, Schwedt TJ, Silvestro M, Swerts DB, Tassorelli C, Tessitore A, Togha M, Vaghi G, Wang SJ, Ashina M, Sacco S. Ornello R, et al. Cephalalgia. 2025 Apr;45(4):3331024241305381. doi: 10.1177/03331024241305381. Epub 2025 Apr 25. Cephalalgia. 2025. PMID: 40277319 Free article.
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases.
Marasco G, Visaggi P, Vassallo M, Fiocca M, Cremon C, Barbaro MR, De Bortoli N, Bellini M, Stanghellini V, Savarino EV, Barbara G. Marasco G, et al. Int J Mol Sci. 2023 Oct 13;24(20):15165. doi: 10.3390/ijms242015165. Int J Mol Sci. 2023. PMID: 37894846 Free PMC article. Review.
Eosinophilic gastrointestinal diseases (EGIDs) are an emerging group of pathological entities characterized by an eosinophil-predominant infiltration of different tracts of the gut in the absence of secondary causes of eosinophilia. According to the specific tract of the g …
Eosinophilic gastrointestinal diseases (EGIDs) are an emerging group of pathological entities characterized by an eosinophil-predominant inf …
Comparison between different types of exercise training in patients with type 2 diabetes mellitus: A systematic review and network metanalysis of randomized controlled trials.
Mannucci E, Bonifazi A, Monami M. Mannucci E, et al. Nutr Metab Cardiovasc Dis. 2021 Jun 30;31(7):1985-1992. doi: 10.1016/j.numecd.2021.02.030. Epub 2021 Mar 20. Nutr Metab Cardiovasc Dis. 2021. PMID: 33965297
Primary endpoint was the effect of exercise versus no exercise on HbA1c and fasting plasma glucose (FPG) at endpoint. Secondary endpoints were body weight and fat, waist circumference, and blood pressure. A comparison of different exercise training modalities (aerobic, res …
Primary endpoint was the effect of exercise versus no exercise on HbA1c and fasting plasma glucose (FPG) at endpoint. Secondary endpo …
BHLHE40/41 regulate microglia and peripheral macrophage responses associated with Alzheimer's disease and other disorders of lipid-rich tissues.
Podleśny-Drabiniok A, Novikova G, Liu Y, Dunst J, Temizer R, Giannarelli C, Marro S, Kreslavsky T, Marcora E, Goate AM. Podleśny-Drabiniok A, et al. Nat Commun. 2024 Mar 6;15(1):2058. doi: 10.1038/s41467-024-46315-7. Nat Commun. 2024. PMID: 38448474 Free PMC article.
Genetic and experimental evidence suggests that Alzheimer's disease (AD) risk alleles and genes may influence disease susceptibility by altering the transcriptional and cellular responses of macrophages, including microglia, to damage of lipid-rich tissues like the brain. Recentl …
Genetic and experimental evidence suggests that Alzheimer's disease (AD) risk alleles and genes may influence disease susceptibility by alte …
Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis.
Ostinelli EG, Schulze M, Zangani C, Farhat LC, Tomlinson A, Del Giovane C, Chamberlain SR, Philipsen A, Young S, Cowen PJ, Bilbow A, Cipriani A, Cortese S. Ostinelli EG, et al. Lancet Psychiatry. 2025 Jan;12(1):32-43. doi: 10.1016/S2215-0366(24)00360-2. Lancet Psychiatry. 2025. PMID: 39701638 Free article.
Second-Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta-Analysis.
Giannini EG, Pasta A, Calabrese F, Labanca S, Marenco S, Pieri G, Plaz Torres MC, Strazzabosco M. Giannini EG, et al. Liver Int. 2025 Jan;45(1):e16222. doi: 10.1111/liv.16222. Liver Int. 2025. PMID: 39720853 Free PMC article.
METHODS: We performed a systematic literature review including randomised, placebo-controlled trials of patients with PBC and incomplete response, or intolerance, to ursodeoxycholic acid, and compared relative risks (RRs) for primary (biochemical response at 52-week) and secon …
METHODS: We performed a systematic literature review including randomised, placebo-controlled trials of patients with PBC and incomplete res …
Spatial-transcriptomic profiling: a new lens for understanding myelofibrosis pathophysiology.
Peroni E, Calistri E, Amato R, Gottardi M, Rosato A. Peroni E, et al. Cell Commun Signal. 2024 Oct 21;22(1):510. doi: 10.1186/s12964-024-01877-3. Cell Commun Signal. 2024. PMID: 39434124 Free PMC article. Review.
MF can be classified into primary and secondary forms, both driven by mutations in genes such as JAK2, CALR, and MPL, which activate the JAK-STAT signaling pathway. ...
MF can be classified into primary and secondary forms, both driven by mutations in genes such as JAK2, CALR, and MPL, which activate …
Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease management.
Bertin L, Crepaldi M, Zanconato M, Lorenzon G, Maniero D, de Barba C, Bonazzi E, Facchin S, Scarpa M, Ruffolo C, Angriman I, Buda A, Zingone F, Barberio B, Savarino EV. Bertin L, et al. Therap Adv Gastroenterol. 2024 Dec 19;17:17562848241303651. doi: 10.1177/17562848241303651. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39711916 Free PMC article. Review.
Despite the availability of a wide range of treatments, many patients experience primary non-response, secondary loss of response, or adverse events, limiting the overall effectiveness of current therapies. ...
Despite the availability of a wide range of treatments, many patients experience primary non-response, secondary loss of response, or …
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World Study.
Maniero D, Ghisa M, Bruschi A, Lorenzon G, Bertin L, Giorgini G, Bendia E, Coletta M, Penagini R, Visaggi P, de Bortoli N, Vespa E, Barchi A, Mari A, Dilaghi E, Annibale B, Iovino P, Di Feo E, Caminati M, Caldart F, Russo S, Marabotto E, Pasta A, Lovero R, Pisani A, Di Sabatino A, Lenti MV, Rossi CM, Merli S, Ribaldone DG, Bonazzi E, Savarino EV. Maniero D, et al. Clin Gastroenterol Hepatol. 2025 Sep 8:S1542-3565(25)00753-0. doi: 10.1016/j.cgh.2025.08.033. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 40930303 Free article.
Eighty-six patients concluded 1 year of treatment, and 78% were still in deep remission, while 15% experienced a loss of histological response at treatment tapering. Primary nonresponders were 8%, and secondary nonresponders were 3%. No serious adverse effects were recorde …
Eighty-six patients concluded 1 year of treatment, and 78% were still in deep remission, while 15% experienced a loss of histological respon …
Nutritional Deficiency in Patients with Heart Failure.
Sciatti E, Lombardi C, Ravera A, Vizzardi E, Bonadei I, Carubelli V, Gorga E, Metra M. Sciatti E, et al. Nutrients. 2016 Jul 22;8(7):442. doi: 10.3390/nu8070442. Nutrients. 2016. PMID: 27455314 Free PMC article. Review.
119 results